| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6121134 | Journal of Clinical Virology | 2013 | 7 Pages |
Abstract
The Bio-Rad Geenius HIV-1/2 Confirmatory Assay is a suitable alternative to the validated Multispot for use in the second stage of CLSI M53 algorithm-I. The Geenius has additional features including traceability and sample and cassette barcoding that improve the quality management/assurance of HIV testing. It is anticipated that the CLSI M53 guideline and assays such as the Geenius will reduce the number of indeterminate test results previously associated with the HIV-1 WB and improve the ability to differentiate HIV-2 infections.
Keywords
CTRLIFACRFPPVNATCDCAPHLGeeniusCLSIDPPHIV-2FDAGenetic systemsM53Association of Public Health LaboratoriesDNAN/Aimmunofluorescence assaypositive predictive valuenegative predictive valuedeoxyribonucleic acidRNAribonucleic acidAlgorithmindenzyme immunoassayEIAnucleic acid testingPCsFood and Drug AdministrationSaskatchewanconfidence intervalcirculating recombinant formnot applicablepositive Centers for Disease Control and PreventionNPV یا negative predictive valuenegativeClinical and Laboratory Standards InstituteIndeterminatenegpolymerase chain reactionPCRWestern blotHIV-1HIVhuman immunodeficiency virusAntibodyAntigenProteinposSynthetic peptideKappaUnTControlGlycoproteinRecombinant glycoprotein
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
L. Malloch, K. Kadivar, J. Putz, P.N. Levett, J. Tang, T.F. Hatchette, K. Kadkhoda, D. Ng, J. Ho, J. Kim,